Loading...

Home
ETF
IFRX

IFRX

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

IFRX News

InflaRx to Engage EMA on AAV Drug Approval Pathways

5d agoNewsfilter

InflaRx Completes $150 Million Underwritten Offering

May 08 2026Newsfilter

InflaRx Scheduled to Announce Q1 Earnings on May 7

May 06 2026seekingalpha

InflaRx Prices Underwritten Offering of 75M Shares at $2.00 Each

May 06 2026seekingalpha

InflaRx N.V. Prices 75 Million Share Offering at $2.00 Each

May 06 2026Newsfilter

InflaRx Unveils New Pre-Clinical Data on Izicopan

May 04 2026Newsfilter

InflaRx to Release Q1 2026 Financial Results on May 7

May 01 2026Newsfilter

InflaRx Regains Compliance with Nasdaq Minimum Bid Price

Apr 28 2026seekingalpha

InflaRx Regains Compliance with Nasdaq Listing Requirements

Apr 28 2026Newsfilter

InflaRx's Izicopan Shows No Time-Dependent CYP3A4 Inhibition

Apr 09 2026Newsfilter

InflaRx to Participate in Biotech Innovation Symposium

Mar 31 2026Newsfilter

InflaRx Scheduled to Announce FY Earnings Results

Mar 18 2026seekingalpha

InflaRx Receives Nasdaq Non-Compliance Notice

Mar 16 2026NASDAQ.COM

InflaRx Receives Nasdaq Warning for Non-Compliance

Mar 13 2026seekingalpha

InflaRx to Participate in Global Healthcare Conference

Feb 26 2026Newsfilter

iFOREX Officially Lists on London Stock Exchange

Feb 25 2026Businesswire